ExoLab Italia Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $5.26M

  • Investors
  • 8

ExoLab Italia General Information

Description

Operator of a biotechnological company intended to create useful products based on vegetable nanovesicles. The company has its laboratory for research, innovation, and production of plant exosome extract from Italian organic agriculture, produces food supplements and cosmetics based on plant exosomes, and specializes in tailor-made consulting services, enabling clients to build research projects that meet their specific needs, up to the development of the formulations of finished products and accompanied by scientific dossiers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Strada Statale 17 Loc Boschetto di Pile
  • 67100 L'Aquila(Abruzzo)
  • Italy
+39 380
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Strada Statale 17 Loc Boschetto di Pile
  • 67100 L'Aquila(Abruzzo)
  • Italy
+39 380

ExoLab Italia Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ExoLab Italia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 18-Dec-2024 $5.26M Completed Generating Revenue
4. Accelerator/Incubator 14-May-2024 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC 24-Oct-2022 $91.6K $656K Completed Generating Revenue
1. Seed Round 23-Dec-2021 $564K $564K Completed Generating Revenue
To view ExoLab Italia’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ExoLab Italia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnological company intended to create useful products based on vegetable nanovesicles. The company h
Biotechnology
L'Aquila, Italy
13 As of 2026

Seoul, South Korea
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ExoLab Italia Competitors (1)

One of ExoLab Italia’s competitors is ExoCoBio, a Venture Capital-Backed company based in Seoul, South Korea.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ExoCoBio Venture Capital-Backed Seoul, South Korea
You’re viewing 1 of 1 competitors. Get the full list »

ExoLab Italia Patents

ExoLab Italia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026190763-A1 Mixture of extracellular vesicles from nettle, ginger and avocado for hair regrowth and anti-hair loss treatments Pending 14-Mar-2025
WO-2026047418-A1 Extracellular vesicles from oranges and their use Pending 30-Aug-2024
WO-2025202836-A1 Extracellular vesicles derived from alpine rose and their use Pending 27-Mar-2024
WO-2025202869-A1 Extracellular vesicles from green tea and their use Pending 27-Mar-2024
WO-2025202869-A4 Extracellular vesicles from green tea and their use Pending 27-Mar-2024 A61K8/9783
To view ExoLab Italia’s complete patent history, request access »

ExoLab Italia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ExoLab Italia Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDP Venture Capital (Rome) Venture Capital Minority
dsm-firmenich Ventures Corporate Venture Capital Minority
Maia Ventures Venture Capital Minority
Riello Investimenti SGR PE/Buyout Minority
UniCredit Start Lab Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

ExoLab Italia FAQs

  • When was ExoLab Italia founded?

    ExoLab Italia was founded in 2020.

  • Where is ExoLab Italia headquartered?

    ExoLab Italia is headquartered in L'Aquila, Italy.

  • What is the size of ExoLab Italia?

    ExoLab Italia has 13 total employees.

  • What industry is ExoLab Italia in?

    ExoLab Italia’s primary industry is Biotechnology.

  • Is ExoLab Italia a private or public company?

    ExoLab Italia is a Private company.

  • What is ExoLab Italia’s current revenue?

    The current revenue for ExoLab Italia is .

  • How much funding has ExoLab Italia raised over time?

    ExoLab Italia has raised $5.93M.

  • Who are ExoLab Italia’s investors?

    CDP Venture Capital (Rome), dsm-firmenich Ventures, Maia Ventures, Riello Investimenti SGR, and UniCredit Start Lab are 5 of 8 investors who have invested in ExoLab Italia.

  • Who are ExoLab Italia’s competitors?

    ExoCoBio is a competitor of ExoLab Italia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process